28 August 2025

‘Bewildering’ decision leaves rare cancer patients behind

6 minute read

Rare Cancers Australia and MSD condemn PBAC’s rejection of a pan-tumour funding model that could have opened access to life-saving therapies.

This content is for AHPRA registered professionals only.
Login Join Now

End of content

No more pages to load

Email Address

Password

Confirm Password

First Name

Last Name

Full Name LEAVE THIS BLANK

What field do you work in?

Type of University work:

Industry Specialty:

Other:

First Name

Last Name

Address 1

Address 2

City

State

Postal Code

Country

Phone

Card Number

Expiration Date /

Security Code (CVC) (what's this?)

Processing...